Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

Research output: Contribution to journal › Letter

Cite this

@article{92826ccb21864ac2b6d9a9f25b5e280f,

title = "Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia",

keywords = "SURVIVAL, PROTEIN-KINASE CK2, B-CELLS, PATHWAY",

author = "Paulo L{\'u}cio and Silva, {Maria Gomes da}",

note = "PMID:23925046 WOS:000329441200019",

year = "2014",

month = "1",

doi = "10.1038/leu.2013.232",

language = "English",

volume = "28",

pages = "179--182",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

AU - Lúcio, Paulo

AU - Silva, Maria Gomes da

N1 - PMID:23925046 WOS:000329441200019

PY - 2014/1

Y1 - 2014/1

KW - SURVIVAL

KW - PROTEIN-KINASE CK2

KW - B-CELLS

KW - PATHWAY

U2 - 10.1038/leu.2013.232

DO - 10.1038/leu.2013.232

M3 - Letter

C2 - 23925046

VL - 28

SP - 179

EP - 182

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -